C. Dogan

发表

The DM-scope registry: a rare disease innovative framework bridging the gap between research and medical care

F. Rivier, F. Chapon, C. Richelme, 2019, Orphanet Journal of Rare Diseases.

Unusual association of a unique CAG interruption in 5′ of DM1 CTG repeats with intergenerational contractions and low somatic mosaicism

G. Bassez, Y. Péréon, Alexis Bertrand, 2018, Human mutation.

Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease

G. Bassez, J. Puymirat, H. Lochmüller, 2018, Orphanet Journal of Rare Diseases.

Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial

T. Heskes, P. Donnan, J. Deux, 2018, The Lancet Neurology.

A large multicenter study of pediatric myotonic dystrophy type 1 for evidence-based management

F. Rivier, C. Richelme, G. Bassez, 2019, Neurology.

Unravelling the myotonic dystrophy type 1 clinical spectrum: A systematic registry-based study with implications for disease classification.

G. Bassez, D. Hamroun, B. Eymard, 2016, Revue neurologique.

Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study

F. Chapon, A. Geille, G. Bassez, 2016, PloS one.

MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1

Nick C Fox, T. Heskes, C. Kennard, 2019, Brain : a journal of neurology.

Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial

T. Heskes, P. Donnan, J. Deux, 2018, The Lancet Neurology.